Choriodecidual Group B streptococcal infection induces miR-155-5p in the fetal lung in Macaca nemestrina

Infection and Immunity

Volumn 83, Issue 10, 2015, Pages 3909-3917

  McAdams, Ryan M ^a   Bierle, Craig J ^a,c,d   Boldenow, Erica ^a   Weed, Samantha ^a   Tsai, Jesse ^b   Beyer, Richard P ^b   MacDonald, James W ^b   Bammler, Theo K ^b   Liggitt, H Denny ^b   Farin, Federico M ^b   Vanderhoeven, Jeroen ^a   Rajagopal, Lakshmi ^a   Waldorf, Kristina M Adams ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d SWEDISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR 9; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 155 5P; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; TUMOR NECROSIS FACTOR;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL IMMORTALIZATION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DECIDUA; FEMALE; FETAL AIRWAY EPITHELIAL CELL; FETUS; FETUS LUNG; GENE OVEREXPRESSION; GROUP B STREPTOCOCCAL INFECTION; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; LEUKOCYTE; LUCIFERASE ASSAY; LUNG DEVELOPMENT; MACACA NEMESTRINA; MICROARRAY ANALYSIS; NONHUMAN; PRIMATE MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEPTOR UPREGULATION; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOCOCCUS AGALACTIAE; ANIMAL; DISEASE MODEL; EMBRYOLOGY; FETUS DISEASE; GENETICS; GROWTH, DEVELOPMENT AND AGING; LUNG; MALE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PREGNANCY; STREPTOCOCCUS; STREPTOCOCCUS INFECTION;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FETAL DISEASES; HUMANS; INTERLEUKIN-6; LUNG; MACACA NEMESTRINA; MALE; PREGNANCY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84944463979     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00695-15     Document Type: Article

References (57)

1. Meis PJ, Goldenberg RL, Mercer BM, Iams JD, Moawad AH, Miodovnik M, Menard MK, Caritis SN, Thurnau GR, Dombrowski MP, Das A, Roberts JM, McNellis D. 2000. Preterm prediction study: is socioeconomic status a risk factor for bacterial vaginosis in black or in white women?AmJ Perinatol 17:41-45. http://dx.doi.org/10.1055/s-2000-7292.
2. Thomas W, Speer CP. 2014. Chorioamnionitis is essential in the evolution of bronchopulmonary dysplasia-the case in favour. Paediatr Respir Rev 15:49-52. http://dx.doi.org/10.1016/j.prrv.2013.09.004.
3. Eulalio A, Schulte L, Vogel J. 2012. The mammalian microRNA response to bacterial infections. RNA Biol 9:742-750. http://dx.doi.org/10.4161/rna.20018.
4. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. 2008. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9:839-845. http://dx.doi.org/10.1038/ni.f.209.
5. Yang Y, Qiu J, Kan Q, Zhou XG, Zhou XY. 2013. MicroRNA expression profiling studies on bronchopulmonary dysplasia: a systematic review and meta-analysis. Genet Mol Res 12:5195-5206. http://dx.doi.org/10.4238/2013.October.30.4.
6. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233. http://dx.doi.org/10.1016/j.cell.2009.01.002.
7. Elton TS, Selemon H, Elton SM, Parinandi NL. 2013. Regulation of the MIR155 host gene in physiological and pathological processes. Gene 532: 1-12. http://dx.doi.org/10.1016/j.gene.2012.12.009.
8. Rubens CE, RaffHV, Jackson JC, Chi EY, Bielitzki JT, Hillier SL. 1991. Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion. J Infect Dis 164:320-330. http://dx.doi.org/10.1093/infdis/164.2.320.
9. Rubens CE, Smith S, Hulse M, Chi EY, van Belle G. 1992. Respiratory epithelial cell invasion by group B streptococci. Infect Immun 60:5157-5163.
10. Pinnas JL, Strunk RC, Fenton LJ. 1979. Immunofluorescence in group B streptococcal infection and idiopathic respiratory distress syndrome. Pediatrics 63:557-561.
11. McAdams RM, Vanderhoeven J, Beyer RP, Bammler TK, Farin FM, Liggitt HD, Kapur RP, Gravett MG, Rubens CE, Adams Waldorf KM. 2012. Choriodecidual infection downregulates angiogenesis and morphogenesis pathways in fetal lungs from Macaca nemestrina. PLoS One 7:e46863. http://dx.doi.org/10.1371/journal.pone.0046863.
12. Adams Waldorf KM, Gravett MG, McAdams RM, Paolella LJ, Gough GM, Carl DJ, Bansal A, Liggitt HD, Kapur RP, Reitz FB, Rubens CE. 2011. Choriodecidual group B streptococcal inoculation induces fetal lung injury without intra-amniotic infection and preterm labor in Macaca nemestrina. PLoS One 6:e28972. http://dx.doi.org/10.1371/journal.pone.0028972.
13. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
14. Weatherall D. 2006. The use of non-human primates in research. Academy of Medical Sciences, Medical Research Council, The Royal Society, and Wellcome Trust, London, United Kingdom.
15. Vanderhoeven JP, Bierle CJ, Kapur RP, McAdams RM, Beyer RP, Bammler TK, Farin FM, Bansal A, Spencer M, Deng M, Gravett MG, Rubens CE, Rajagopal L, Adams Waldorf KM. 2014. Group B streptococcal infection of the choriodecidua induces dysfunction of the cytokeratin network in amniotic epithelium: a pathway to membrane weakening. PLoS Pathog 10:e1003920. http://dx.doi.org/10.1371/journal.ppat.1003920.
16. Martin TR, Rubens CE, Wilson CB. 1988. Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung. J Infect Dis 157:91-100. http://dx.doi.org/10.1093/infdis/157.1.91.
17. Musser JM, Mattingly SJ, Quentin R, Goudeau A, Selander RK. 1989. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci U S A 86:4731-4735. http://dx.doi.org/10.1073/pnas.86.12.4731.
18. Yue J, Sheng Y, Orwig KE. 2008. Identification of novel homologous microRNA genes in the rhesus macaque genome. BMC Genomics 9:8. http://dx.doi.org/10.1186/1471-2164-9-8.
19. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80. http://dx.doi.org/10.1186/gb-2004-5-10-r80.
20. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, Yefanov A, Lee H, Zhang N, Robertson CL, Serova N, Davis S, Soboleva A. 2013. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res 41:D991-D995. http://dx.doi.org/10.1093/nar/gks1193.
21. Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. 1976. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17:62-70. http://dx.doi.org/10.1002/ijc.2910170110.
22. Yin Y, Wang F, Ornitz DM. 2011. Mesothelial- and epithelial-derived FGF9 have distinct functions in the regulation of lung development. Development 138:3169-3177. http://dx.doi.org/10.1242/dev.065110.
23. Zhu S, Si ML, Wu H, Mo YY. 2007. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282:14328-14336. http://dx.doi.org/10.1074/jbc. M611393200.
24. Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, Jun JK. 1999. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 181:773-779. http://dx.doi.org/10.1016/S0002-9378(99)70299-1.
25. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI. 1997. Amniotic fluid cytokines (interleukin-6, tumor necrosis factoralpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. AmJ Obstet Gynecol 177:825-830. http://dx.doi.org/10.1016/S0002-9378(97)70276-X.
26. Munshi UK, Niu JO, Siddiq MM, Parton LA. 1997. Elevation of interleukin- 8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol 24:331-336. http://dx.doi.org/10.1002/(SICI)1099-0496(199711)24:5<331::AID-PPUL5>3.0.CO;2-L.
27. Sheedy FJ, O'Neill LA. 2008. Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis 67(Suppl 3):iii50-iii55. http://dx.doi.org/10.1136/ard.2008.100289.
28. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. 2007. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104:1604-1609. http://dx.doi.org/10.1073/pnas.0610731104.
29. Foster PS, Plank M, Collison A, Tay HL, Kaiko GE, Li J, Johnston SL, Hansbro PM, Kumar RK, Yang M, Mattes J. 2013. The emerging role of microRNAs in regulating immune and inflammatory responses in the lung. Immunol Rev 253:198-215. http://dx.doi.org/10.1111/imr.12058.
30. Sonkoly E, Stahle M, Pivarcsi A. 2008. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 18:131-140. http://dx.doi.org/10.1016/j.semcancer.2008.01.005.
31. Staedel C, Darfeuille F. 2013. MicroRNAs and bacterial infection. Cell Microbiol 15:1496-1507. http://dx.doi.org/10.1111/cmi.12159.
32. Schall TJ, Bacon K, Toy KJ, Goeddel DV. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347:669-671. http://dx.doi.org/10.1038/347669a0.
33. Pan ZZ, Parkyn L, Ray A, Ray P. 2000. Inducible lung-specific expression of RANTES: preferential recruitment of neutrophils. Am J Physiol Lung Cell Mol Physiol 279:L658-L666.
34. Bose C, Laughon M, Allred EN, Van Marter LJ, O'Shea TM, Ehrenkranz RA, Fichorova R, Leviton A. 2011. Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation. Pediatr Res 69:347-353. http://dx.doi.org/10.1203/PDR.0b013e31820a58f3.
35. Shahrara S, Proudfoot AE, Woods JM, Ruth JH, Amin MA, Park CC, Haas CS, Pope RM, Haines GK, Zha YY, Koch AE. 2005. Amelioration of rat adjuvant-induced arthritis by Met-RANTES. Arthritis Rheum 52: 1907-1919. http://dx.doi.org/10.1002/art.21033.
36. Dobaczewski M, Xia Y, Bujak M, Gonzalez-Quesada C, Frangogiannis NG. 2010. CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol 176:2177-2187. http://dx.doi.org/10.2353/ajpath.2010.090759.
37. Coffey E, Newman DR, Sannes PL. 2013. Expression of fibroblast growth factor 9 in normal human lung and idiopathic pulmonary fibrosis. J Histochem Cytochem 61:671-679. http://dx.doi.org/10.1369/0022155413497366.
38. White AC, Xu J, Yin Y, Smith C, Schmid G, Ornitz DM. 2006. FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains. Development 133:1507-1517. http://dx.doi.org/10.1242/dev.02313.
39. Yin Y, White AC, Huh SH, Hilton MJ, Kanazawa H, Long F, Ornitz DM. 2008. An FGF-WNT gene regulatory network controls lung mesenchyme development. Dev Biol 319:426-436. http://dx.doi.org/10.1016/j.ydbio.2008.04.009.
40. Pottier N, Maurin T, Chevalier B, Puissegur MP, Lebrigand K, Robbe- Sermesant K, Bertero T, Lino Cardenas CL, Courcot E, Rios G, Fourre S, Lo-Guidice JM, Marcet B, Cardinaud B, Barbry P, Mari B. 2009. Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS One 4:e6718. http://dx.doi.org/10.1371/journal.pone.0006718.
41. Cardoso WV, Itoh A, Nogawa H, Mason I, Brody JS. 1997. FGF-1 and FGF-7 induce distinct patterns of growth and differentiation in embryonic lung epithelium. Dev Dyn 208:398-405. http://dx.doi.org/10.1002/(SICI)1097-0177(199703)208:3>398::AID-AJA10>3.0.CO;2-X.
42. Tichelaar JW, Lu W, Whitsett JA. 2000. Conditional expression of fibroblast growth factor-7 in the developing and mature lung. J Biol Chem 275:11858-11864. http://dx.doi.org/10.1074/jbc.275.16.11858.
43. Dheda K, Van-Zyl Smit RN, Sechi LA, Badri M, Meldau R, Symons G, Khalfey H, Carr I, Maredza A, Dawson R, Wainright H, Whitelaw A, Bateman ED, Zumla A. 2009. Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS One 4:e4689. http://dx.doi.org/10.1371/journal.pone.0004689.
44. Cannas A, Calvo L, Chiacchio T, Cuzzi G, Vanini V, Lauria FN, Pucci L, Girardi E, Goletti D. 2010. IP-10 detection in urine is associated with lung diseases. BMC Infect Dis 10:333. http://dx.doi.org/10.1186/1471-2334-10-333.
45. Clahsen T, Schaper F. 2008. Interleukin-6 acts in the fashion of a classical chemokine on monocytic cells by inducing integrin activation, cell adhesion, actin polymerization, chemotaxis, and transmigration. J Leukoc Biol 84:1521-1529. http://dx.doi.org/10.1189/jlb.0308178.
46. Kallapur SG, Jobe AH, Ikegami M, Bachurski CJ. 2003. Increased IP-10 and MIG expression after intra-amniotic endotoxin in preterm lamb lung. Am J Respir Crit Care Med 167:779-786. http://dx.doi.org/10.1164/rccm.2203030.
47. Rao R, Nagarkatti P, Nagarkatti M. 2014. Staphylococcal enterotoxin B-induced microRNA-155 targets SOCS1 to promote acute inflammatory lung injury. Infect Immun 82:2971-2979. http://dx.doi.org/10.1128/IAI.01666-14.
48. Diamant NE. 1985. Development of esophageal function. Am Rev Respir Dis 131:S29-S32.
49. Kalache KD, Chaoui R, Bollmann R. 1997. Doppler assessment of tracheal and nasal fluid flow during fetal breathing movements: preliminary observations. Ultrasound Obstet Gynecol 9:257-261. http://dx.doi.org/10.1046/j.1469-0705.1997.09040257.x.
50. Pollack JA, Moise KJ, Jr, Tyson WR, Galan HL. 2003. The role of fetal breathing motions compared with gasping motions in pulmonary airway uptake of intra-amniotic iron dextran. AmJ Obstet Gynecol 189:958-962. http://dx.doi.org/10.1067/S0002-9378(03)00719-1.
51. Matute-Bello G, Frevert CW, Martin TR. 2008. Animal models of acute lung injury. AmJ Physiol Lung Cell Mol Physiol 295:L379-L399. http://dx.doi.org/10.1152/ajplung.00010.2008.
52. Kallapur SG, Bachurski CJ, Le Cras TD, Joshi SN, Ikegami M, Jobe AH. 2004. Vascular changes after intra-amniotic endotoxin in preterm lamb lungs. Am J Physiol Lung Cell Mol Physiol 287:L1178-L1185. http://dx.doi.org/10.1152/ajplung.00049.2004.
53. Jobe AH. 2011. The new bronchopulmonary dysplasia. Curr Opin Pediatr 23:167-172. http://dx.doi.org/10.1097/MOP.0b013e3283423e6b.
54. Speer CP. 2003. Inflammation and bronchopulmonary dysplasia. Semin Neonatol 8:29-38. http://dx.doi.org/10.1016/S1084-2756(02)00190-2.
55. Yoder BA, Coalson JJ. 2014. Animal models of bronchopulmonary dysplasia. The preterm baboon models. Am J Physiol Lung Cell Mol Physiol 307:L970-L977. http://dx.doi.org/10.1152/ajplung.00171.2014.
56. Coalson JJ. 2006. Pathology of bronchopulmonary dysplasia. Semin Perinatol 30:179-184. http://dx.doi.org/10.1053/j.semperi.2006.05.004.
57. Beam KS, Aliaga S, Ahlfeld SK, Cohen-Wolkowiez M, Smith PB, Laughon MM. 2014. A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants. J Perinatol 34:705-710. http://dx.doi.org/10.1038/jp.2014.126.